Sabine Nöhring

Title: Sabine Nöhring: Innovator in Recombinant Glycoproteins

Introduction

Sabine Nöhring is a notable inventor based in Seeburg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. Her work has implications for various medical applications, especially in the human circulatory system.

Latest Patents

Nöhring holds a patent for "Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof." This invention relates to novel recombinant glycoproteins that serve as messenger substances, signaling substances, promoters, stimulators, and initiators in the animal, particularly human, circulatory system. The patent details a method for producing these glycoproteins and pharmaceutical agents that contain them. It specifically focuses on recombinant human glycoproteins, including differentiation factors, growth factors, thrombolytic agents, thromboprophylactic agents, coagulation factors, interferons, and interleukins.

Career Highlights

Throughout her career, Nöhring has demonstrated a commitment to advancing medical science through her innovative research. Her patent reflects her expertise in biotechnology and her dedication to improving health outcomes through the development of new therapeutic agents.

Collaborations

Nöhring has collaborated with notable colleagues, including Werner Reutter and Rudolf Tauber. These partnerships have likely contributed to her success and the advancement of her research in the field.

Conclusion

Sabine Nöhring is a pioneering inventor whose work in recombinant glycoproteins has the potential to transform medical treatments. Her contributions to biotechnology highlight the importance of innovation in addressing health challenges.